INLIF (INLF) shares were down 43% in Thursday premarket activity, extending the previous session's 88% decline.
Sleep Number (SNBR) stock was down 40% after the company said in a regulatory filing that it received a Nasdaq delisting notice related to its Chapter 11 filing and associated public interest and compliance concerns.
NovoCure (NVCR) shares were down 21% after a phase 3 trial evaluating its Tumor Treating Fields therapy in patients with newly diagnosed glioblastoma failed to meet its primary endpoint.
Elicio Therapeutics (ELTX) stock was down 20%, following Wednesday's 70% gain.